BioLineRx Ltd. (BLRX)

NASDAQ: BLRX · Real-Time Price · USD

3.380

+0.123 (3.78%)

At close: Dec 5, 2025, 4:00 PM EST

3.360

-0.020 (-0.59%)

After-hours: Dec 5, 2025, 4:10 PM EST

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec '23 Dec 31, 2023	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009
License	17.00M	Log In	Log In
Oncology and Hematology	700.72K	Log In	Log In
Oncology and Hematology Growth	-99.38%	Log In	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec '23 Dec 31, 2023	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009
Israel	17.70M	Log In	Log In
Israel Growth	-84.36%	Log In	Log In